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Abstract
Background: Assessment of dual time point (DTP) positron emission tomography was carried out with the aim of a
quantitative determination of Km, the metabolic uptake rate of [18F]ﬂuorodeoxyglucose as a measure of glucose
consumption.
Methods: Starting from the Patlak equation, it is shown that Km ≈ mt/c0a + V¯r/τa, wheremt is the secant slope of the
tissue response function between the dual time point measurements centered at t = t0. c0a = ca(t0) denotes arterial
tracer concentration, V¯r is an estimate of the Patlak intercept, and τa is the time constant of the ca(t) decrease. We
compared the theoretical predictions with the observed relation between Ks = mt/c0a and Km in a group of nine
patients with liver metastases of colorectal cancer for which dynamic scans were available, and Km was derived from
conventional Patlak analysis. Twenty-two lesion regions of interest (ROIs) were evaluated. ca(t) was determined from a
three-dimensional ROI in the aorta. Furthermore, the correlation between Km and late standard uptake value (SUV) as
well as retention index was investigated. Additionally, feasibility of the approach was demonstrated in a whole-body
investigation.
Results: Patlak analysis yielded a mean Vr of V¯r = 0.53± 0.08 ml/ml. The patient averaged τa was 99± 23 min. Linear
regression between Patlak-derived Km and DTP-derived Ks according to Ks = b · Km + a yielded b = 0.98 ± 0.05 and
a = −0.0054± 0.0013 ml/min/ml (r = 0.98) in full accordance with the theoretical predictions b = 1 and a ≈ −V¯r/τa.
Ks exhibits better correlation with Km than late SUV and retention index, respectively. K
(c)
s = Ks + V¯r/τa is proposed as
a quantitative estimator of Km which is independent of patient weight, scan time, and scanner calibration.
Conclusion: Quantiﬁcation of Km from dual time point measurements compatible with clinical routine is feasible.
The proposed approach eliminates the issues of static SUV and conventional DTP imaging regarding inﬂuence of
chosen scanning times and inter-study variability of the input function. Ks and K
(c)
s exhibit improved stability and
better correlation with the true Km. These properties might prove especially relevant in the context of radiation
treatment planning and therapy response control.
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Background
Formany years, quantiﬁcation of themetabolic rate of glu-
cose consumption with dynamic [18F]ﬂuorodeoxyglucose
(FDG) positron emission tomography (PET) using the so-
called Patlak plot, a procedure most clearly described by
Patlak in his seminal papers [1,2], has proven valuable in
PET research and clinical routine.
However, in the clinical oncological setting, quantiﬁca-
tion is mostly restricted to the ubiquitously used standard
uptake value (SUV). The reason is twofold: (1) no need
(or even inability) to determine the arterial input function
(AIF) and (2) inability to perform dynamic whole-body
investigations.
Without question, the SUV (deﬁned as the tracer uptake
at a certain time point normalized to injected dose per
unit body weight) has proven a valuable means of achiev-
ing a certain level of quantitative description, thus allow-
ing, e.g., deﬁnition of standardized evaluation schemes
(see [3] for an overview).
The approach, however, has known shortcomings [4-6].
SUVs do not directly provide information about the tracer
kinetics but, by their very nature, only a static snapshot
somewhere on the tissue response function (TRF). Natu-
rally, SUVs are varying along the given TRF and are thus
prone to variability when not determined at a strictly stan-
dardized time. Since SUVs do not contain any information
of the actual rate of tracer accumulation (related to the
slope of the tissue response function), TRFs from diﬀerent
tissues might in extreme cases even intersect at a certain
time (thus exhibiting identical SUVs and zero image con-
trast at this moment) while having completely diﬀerent
kinetic properties. Tissue SUV stability is further com-
promised by not accounting for the sizable inter-study
variability of arterial blood SUV which directly inﬂuences
the actually obtained tissue uptake.
One quite extensively investigated way around the ‘snap-
shot problem’ is dual time point (DTP) investigations [7,8]
in which two successive whole-body scans are performed
to obtain information regarding the rate of tracer accumu-
lation. While being undoubtly valuable in discriminating
between tumor and inﬂammation, quantitative evaluation
of DTP measurements is usually restricted to computa-
tion of a so-called retention index, RI, representing the
percentage change of SUVmax or SUVmean between early
and late images (see, e.g., [9,10]). However, the retention
index, too, depends on the acquisition time of (and time
diﬀerence between) early and late PET scan and, there-
fore, requires the same strict standardization as the SUV
approach to provide useful quantitative measures. The
retention index, too, is aﬀected by the mentioned AIF
variability at late times due to the evoked changes of the
TRF slope.
There also have been attempts to directly use the TRF
slope obtained in dynamic scans as a substitute for actual
kinetic modeling [11,12] while avoiding measurements
of tracer concentration in blood. However, a convinc-
ing physiological interpretation of the slope parameter
is missing. Furthermore, the approach suﬀers from the
same problems as SUVs and retention index regarding
the uncontrolled inﬂuence of the inter- and intra-subject
variability of the AIF.
In this study, we propose a new assessment of DTP (and,
more generally, TRF slope)-basedmethods with the aim of
a quantitative determination of Km, the metabolic uptake
rate of FDG. We demonstrate that starting from the Pat-
lak model, one can derive an analytical relation between
Km and the TRF slopemt , which only requires the image-
based determination of the AIF during the respective late
PET scans. The derived relation is especially compatible
with dual time point whole-body investigations.
In this retrospective investigation, we evaluate the new
approach in a group of patients with liver metastases of
colorectal cancer for which Km was determined, both,
by conventional Patlak analysis of the fully dynamic PET
scans as well as by the newly developed approach.
Methods
Theory
It is well known that the TRF after a bolus injec-
tion of FDG appears to be approximately linear at later
times. Closer inspection, however, reveals, that the curve
exhibits a ﬁnite curvature: the slope decreases with time
due to the continuously decreasing AIF (see Figure 1).
In the Appendix, we demonstrate that for times t when
the Patlak equation is valid (usually for t > 20 − 30
min), the ratio between the instantaneous values of TRF
slope and AIF level can be expressed in terms of the
parameters Km and Vr of the Patlak model and the time
constant τa describing the essentially mono-exponential
decrease of the AIF in the considered time window. It
is shown in the Appendix that the TRF slope at t = t0
is very nearly identical to the slope of the secant con-
necting the boundary points of a ﬁnite symmetric time
interval around t0 (and also to the average slope in this
interval).
One ﬁnally arrives at the relation









where mt is the secant (or average) TRF slope in the cho-
sen time interval centered at t0 and c0a = ca(t0) (see
Figure 1).
The rate Ks deﬁned by Equation 2 (i.e., the ratio between
the TRF slope and AIF level at time t0) can be deter-
mined from measurements during the late phase alone.
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Figure 1 AIF plus TRF calculated forK1 = 0.3ml/min/ml, k2 = 0.5 /min, k3 = 0.08 /min. The TRF does not become linear at later times but
exhibits a visible curvature. However, the slope at some time point t0 (t0 = 60 min in this example) is nearly identical to the slope of the secant
connecting the boundary points of a ﬁnite time interval centered at t0. The AIF is scaled such that ca(t0) = 1. The data accessible in a DTP
measurement are indicated by the square plotting symbols. For further details, see the main text.
Contrary to the Patlak method, knowledge of the full AIF
is not required. To the extent that Ks  Vr/τa, Ks might
directly serve as an (negatively biased) approximation of
Km. Moreover, to the extent that Vr can be replaced by a
suitable constant value V¯r , Ks diﬀers from Km only by a
τa- dependent oﬀset that can be added to Ks to obtain a
corrected value




that approximates Km quite accurately (see Appendix and
Figure 1).
We have compared these theoretical predictions with
the actually observed relation between Ks and Km in a
group of patients with liver metastases for which fully
dynamic scans were performed.
Study sample
The investigated patient group included nine male sub-
jects with liver metastases of colorectal cancer (mean
age 62.8 years, range 48 to 76). For each patient, one to
three dynamic PET scans of 60 min duration were per-
formed (altogether 15 scans). Scans started immediately
after injection of 346 to 430 MBq FDG. The scans were
performed with an ECAT EXACT HR+ (Siemens/CTI,
Knoxville, TN, USA). The acquired data were sorted into
23 to 31 frames with 10 to 20 s duration during bolus
passage, 30 to 150 s duration until 10 min post-injection
(p.i.), and 300 s duration afterwards. Tomographic images
were reconstructed using attenuation-weighted OSEM
reconstruction (6 iterations, 16 subsets, 6 mm FWHM
Gaussian ﬁlter).
Additionally, feasibility of the generation of paramet-
ric K (c)s maps was demonstrated in a whole-body FDG
investigation of a 63-year-old woman with bronchial car-
cinoma of the right lung and lymph nodemetastases of the
right hilar region and the mediastinum (Philips Ingenuity
TF PET/MR (Philips, Cleveland, OH, USA), injected dose
273 MBq, ﬁrst scan 67 min p.i. (2 min per bed position),
second scan 117 min p.i. (1.5 min per bed position)).
Data evaluation
Region of interest (ROI) deﬁnition was performed using
ROVER (ABX, Radeberg, Germany) [13,14]. The AIF was
determined from a roughly cylindrical three-dimensional
(3D) ROI centered in the aorta using a concentric safety
margin of at least 1 cm to exclude partial volume eﬀects.
3D lesion ROIs were deﬁned in 22 lesions, and the respec-
tive TRFs were computed. Further data analysis was
performed using the R software for statistical computa-
tion [15].
For all 22 lesions, Km and Vr were derived from the con-
ventional Patlak analysis of the full dynamic data later than
20 min p.i. (at which time all Patlak plots already were
linear). For comparison with the corresponding result of
the subsequent DTP evaluation, τa was determined from a
mono-exponential ﬁt to the complete AIF data in the time
window used for the Patlak analysis. Variability of τa and
Vr was expressed as mean ± standard deviation (SD).
Dual time point data were generated from the data 20
to 30 min and 50 to 60 min p.i., yielding two pairs of ca
and ct values which were assigned to the respective frame
centers t−/+ = 25/55 min (which corresponds to t0 =
0.5 · (t− + t+) = 40 min and t = t+ − t− = 30 min).
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t+ − t− , (4)
where c0a was calculated from the exponential connect-
ing the two points (t−, c−a ) and (t+, c+a ) which yields c0a =√
c−a · c+a .
For K (c)s computation according to Equation 3, we ﬁxed
Vr to the mean of the Patlak evaluation for all lesions
(V¯r = 0.53 ml/ml), while τa was estimated individually for
each study from the exponential connecting (t−, c−a ) and
(t+, c+a ) as
τa = tln (c−a /c+a )
.
Additionally, the retention index was computed as
RI = ct/c−t . Linear regression analysis was performed
between Km and Ks, K (c)s , RI, and c+t (the SUV of the
lesions in the late image), respectively. Parametric images
of Ks, K (c)s , and Km were generated for visual comparison
after ﬁltering of the DTP image data with a bilateral ﬁl-
ter [16] (spatial ﬁlter width 9 mm, intensity ﬁlter width 2.5
SUV).
Inﬂuence of image noise
Considering a single voxel and neglecting the (much
smaller) statistical error of the ROI-based c0a value, it fol-
lows from Equation 4 that the relative statistical error of










which decreases with increasing concentration diﬀerence
ct . Taking into account that measurement times of both
dual time point measurements might be adjusted in such













where the ﬁnal ratio represents the relative SUV error of
the second dual time point measurement. For t ≈ 30
min and typical tumor accumulation rates of ≈ 2% to 4%
per minute, one can thus estimate that the relative errors
of Ks are about 2.5 to 4 times higher than the correspond-
ing SUV errors (the statistical error of K (c)s is quite similar
since the small correction term V¯r/τa cannot contribute
much to the total statistical uncertainty of K (c)s ). Although
the noise in the parametric maps can thus be expected to
be distinctly higher than that in the uptake images, the
resulting visual quality is still quite satisfactory for reason-
able choices of t ( 30 min) as will be demonstrated in
the following.
Results
The obtained results are summarized in Tables 1 and 2.
Figure 2A shows the correlation between Patlak-derived
Km and Ks. The solid line is the line of identity, and the
dashed line is the linear regression result. The linear cor-
relation is very good, and the ﬁtted slope is identical to one
within the given error limits of about 5% (Table 2). The
ﬁtted intercept of −0.54 ml/min/100 ml thus represents
the experimentally observed average underestimate of the
true Km by Ks.
Figure 2B presents the correlation between Km and
K (c)s = Ks + K0 according to Equation 3. The correction
term K0 = V¯r/τa was computed using the average Vr
derived from the Patlak analysis of all 22 lesions, V¯r = 0.53
ml/ml, and individual (investigation-speciﬁc) time con-
stants τa derived from the DTP data (the independent
determination of τa from the full dynamic data in the
Patlak time window - performed as a consistency check -
yielded essentially the same result (104±20min (dynamic)
vs. 99 ± 23 min (DTP)) but was not used further). As
can be seen, the degree of linear correlation is distinctly
improved in comparison to Figure 2A. Furthermore, the
ﬁtted straight line now essentially coincides with the line
of identity. Consequently, the average diﬀerence between
Km and K (c)s amounts to only 1.4 ± 4.1% and exceeds 10%
only in a single lesion.
For comparison, Figure 3A,B presents the correlations
between Km and the late SUV uptake c+t , and Km and the
retention index RI, respectively. Obviously, the correla-
tion between Km and c+t is rather poor. The correlation
between Km and the RI is substantially higher but still
clearly below the degree of correlation between Km and Ks
or K (c)s . The correlation in Figure 3A is clearly distorted by
the group of the six highest observed SUV values which
correspond to only moderately high Km values. This phe-
nomenon might be explained by the exceptionally high
c0a values observed in the respective patients (see inset
graphic in Figure 3A).





Vr (ml/ml) 0.53 ± 0.08 0.39 − 0.68
Dynamic τa (min) 104 ± 20 79 − 156
DTP τa (min) 99 ± 23 81 − 172
c0a (SUV) 3.1 ± 0.7 2.4 − 4.5
‘Dynamic τa ’ denotes the result derived from the full dynamic AIF data with
t > 20min. ‘DTP τa ’ was computed solely from the used DTP data. Only the latter
was used in further computations.
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Table 2 Linear regression results: Pearson correlation
coeﬃcient r and the obtained regression parameters are
shown
r Slope (mean± SD) Intercept (mean± SD)
Km vs. Ks 0.98 0.98 ± 0.05 −0.54 ± 0.13
Km vs. K
(c)
s 0.99 0.98 ± 0.04 0.04 ± 0.10
Km vs. c
+
t 0.60 1.62 ± 0.48 2.81 ± 1.33
Km vs. RI 0.88 11.38 ± 1.34 5.44 ± 3.79
All correlations were found to be statistically signiﬁcant with p < 0.005. Chosen
units are in milliliters per minute per 100 ml for Km , Ks , and K
(c)
s ; SUV for c
+
t ; and
percentage for RI (from which the respective slope and intercept units follow).
Figure 4A provides one example of a lesion uptake
image, and the corresponding parametric images of Ks,
K (c)s , and Km are shown in Figure 4B,C,D, respectively, all
of which are displayed in a common scale. The compara-
ble, enhanced target-to-background contrast of the three
parametric images relative to the uptake image is obvious.
In agreement with the theoretical expectation and the ROI
data in Figure 2, there is good quantitative concordance
betweenKm andK (c)s , whileKs exhibits a constant negative
bias of about K0 ≈ −0.5 ml/min/100 ml in comparison to
Km.
Finally, Figure 5 demonstrates the feasibility of generat-
ing parametric K (c)s maps of reasonable statistical quality
for a typical DTP whole-body FDG study.
Discussion
Our main result is that in the investigated patient group,
there is a very pronounced linear correlation Ks = a + b ·
Km, where b is very nearly equal to one (see Figure 2A).
This behavior is in complete agreement with the formal-
ism presented in the Appendix, notably Equation 13: the
variations of the (small) term Vr/τa should be essentially
uncorrelated to Km so that a high (but slightly “noisy”) lin-
ear correlation between Km and Ks with a slope near one
is predicted. Furthermore, according to Equation 13, the
modulus of the intercept, a = −0.0054ml/min/ml, should
be approximately equal to the average of Vr/τa in the
investigated patient group. This prediction, too, is in com-
plete agreement with the actual values of Vr (determined
from Patlak analysis) and τa, namely V¯r = (0.53 ± 0.08)
ml/ml and τ¯a = (99 ± 23) min.
The second important ﬁnding is the fact that the degree
of correlation as well as quantitative agreement between
Km and Ks can be further improved by assuming a rea-
sonable constant value for V¯r (since Vr is inaccessible
in DTP measurements) and determining individually the
rate of decrease, τa, of the AIF (which can be esti-
mated from the DTP measurement). The corrected Ks,
K (c)s = Ks + V¯r/τa, exhibits an improved correlation
to Km (due to compensation of the τa variability) and
also improved quantitative concordance as long as V¯r is
roughly in accord with the individual true Vr . Both phe-
nomena are illustrated clearly in Figure 2B. The distinctly
improved correlation (compared to Figure 2A) is achieved
by the individual correction of the τa inﬂuence. The resid-
ual deviations from the perfect correlation in Figure 2B
are mainly due to the variability of Vr . A nearly perfect
quantitative agreement with Km is observed since V¯r was
set to the mean of the actual Vr values derived from
the Patlak analysis. This obviously would not be possible
when considering realistic DTP measurements (without
a preceding complete dynamic study), and a less-than-
perfect quantitative agreement should be expected in this
case. Nevertheless, as the comparison of Figure 2A,B
suggests, performing the correction with some roughly
correct value for V¯r will always decrease the bias between
Ks and Km.
The rather small variability of tumor Vr observed in the
present investigationmight seem surprising. However, the
square of k2/(k2 + k3) appearing in Equation 6 will never
deviate very much from unity since for FDG, k2 quite
Figure 2 Correlation between the metabolic rateKm and the DTP-derived rate constants. (A) Km and Ks and (B) Km and K(c)s . Solid black lines
represent the line of identity; dashed lines represent the least squares straight line ﬁts to the data.
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Figure 3 Correlation between the metabolic rateKm and Standard Uptake Value and retention index, respectively. (A) Km and c+t (in SUV
units) and (B) Km and retention index (in percent). c
+
t is the tissue uptake at t = 55 min. Dashed lines represent the least squares straight line ﬁts to
the data. The inset graph in (A) additionally provides the correlation between c0a and c
+
t , which helps to explain the group of data points above the
regression line with SUV>8 (see the ‘Discussion’ section).
generally is distinctly larger than k3. The variability of Vr
is thus mostly controlled by the ﬁrst term, K1/k2. Since
both K1 and k2 are usually identiﬁed as being associated
with the facilitated diﬀusion across the cell membrane,
it might very well be expected that the ratio K1/k2 is
essentially constant, independent of the actual K1. This
might be the underlying reason for the low variability
of Vr observed in this study. Whether Vr variability is
higher in other tumors remains to be investigated, but
we believe this to be unlikely. Vr should never be much
larger than about 0.6 to 0.7 ml/ml which appears to
be a rough upper bound for the K1/k2 ratio. Accord-
ing to our own data, this is true, e.g., in the human
brain (K1/k2 ≈ 0.1/0.15 = 0.67 ml/ml) as well as the
myocardium (K1/k2 ≈ 0.6/1.4 = 0.43 ml/ml). Vr in these
organs is rather low (≈ 0.3 ml/ml) due to the large k3 in
both tissues.
We surmise, therefore, that Vr in tumors (and healthy
tissue) will never deviate too much from the value of 0.53,
ml/ml used for Ks correction in this study. The corrected
rate,K (c)s , can then be expected to be a less biased estimate
of Km than Ks over a substantial range of actually realized
Vr values between about 0.2 and 0.7 ml/ml (see Figures 6
and 7). Whether K (c)s does oﬀer any advantages over Ks
in terms of clinical relevance remains to be seen, but the
improved correlation with Km seems justiﬁcation enough
to perform the correction.
The very high correlation between K (c)s (or Ks) and Km
is to be compared with the markedly inferior correla-
tion between Km and late SUV (c+t ) and retention index
RI, respectively (Figure 3). Since all these parameters are
ultimately intended as surrogate parameters of Km, the
superiority ofKs seems obvious. Since in the present study
the retention index is computed from exactly the same
DTP tissue data as Ks, it is worth to point out that the sole
factor responsible for the much better Ks(Km) correlation
is adequate consideration of the substantial inter-subject
c0a variability (see Table 1). Indeed, one could write Ks =
ct/t/c0a = ct/c−t /t · c−t /c0a = RI/t · c−t /c0a, where
t is just a constant in the present context. To some
extent, Ks might thus be considered just a more sensible
deﬁnition of a retention index where the uptake diﬀerence
ct is normalized to c0a (as well as t) instead of c−t .
The observed very low correlation between late SUV
and Km is caused by the six data points with SUV>8
in Figure 3A. Leaving these six points out increases
Figure 4 Liver metastasis of a colorectal carcinoma exhibiting a central necrosis. (A) A representative sagittal slice of uptake and the
corresponding parametric images of (B) Ks , (C) K
(c)
s , and (D) Km , respectively, are shown. The means of the rate constants over the lesion are as
follows: Ks = 2.23 ml/min/100 ml, K(c)s = 2.80 ml/min/100 ml, and Km = 2.90 ml/min/100 ml, demonstrating a quite satisfactory quantitative
agreement between K(c)s and Km .
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Figure 5 Comparison of parametric images of SUV andK (c)s . (A) FDG SUV 67 min. p.i. and (B) parametric K (c)s map in a 63-year-old woman. The
patient has a bronchial carcinoma of the right lung and lymph node metastases of the right hilar region and the mediastinum (coronal maximum
projection). Note the diﬀerent regional contrast and the used units in both images.
the correlation coeﬃcient to 0.94 which is in good
agreement with published data [17]. Closer inspection
revealed exceptionally high c0a values (see inset graphic
in Figure 3A) for the aﬀected data points which might
have physiological reasons but could also hint at erro-
neous SUV calibration (for which, however, a retrospec-
tive inspection did not ﬁnd any evidence). In any case,
the data demonstrate the high sensitivity of SUV evalu-
ations to variations of the AIF level and incorrect SUV
calibration.
The comparison of uptake and parametric images in
Figure 4 demonstrates that Ks as well as K (c)s reproduces
the essential features of the Patlak Km image, notably
the increased contrast between metastasis and liver back-
ground. Regarding the targeted lesions, the K (c)s image is,
moreover, in good quantitative agreement with the Km
image and could thus serve as a basis for regional quan-
titative evaluation. We, therefore, believe it is worthwhile
to investigate the potential suitability of K (c)s as a quan-
titative estimator (and not just a surrogate) of Km more
thoroughly in future studies. Figure 5 demonstrates that
reasonable statistical quality of the K (c)s map can in fact be
achieved in whole-body DTP investigations as well.
Compared to more conventional approaches, our
approach has several relevant beneﬁts. The most impor-
tant one in our view is the potential to perform fully
Figure 6 Visualization of the diﬀerence betweenKm andKs. The plots cover a substantial range of the parameters k2 and k3, assuming a ﬁxed
ratio K1/k2 = 0.7 ml/ml (a rationale for ﬁxing this ratio is given in the discussion above). Top left, Km ; top right, Vr ; bottom left, absolute diﬀerence
(Km − Ks); and bottom right, fractional diﬀerence ((Km − Ks)/Km). Parameters and their respective units: k2, k3 (1/min); Vr (ml/ml); and Km , Ks
(ml/min/100 ml). Moving along the line, Vr ≈ 0.55 ml/ml between Km = 1 and 4 ml/min/100 ml corresponds approximately to the experimental
data of Figure 2A.
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Figure 7 Visualization of the diﬀerence betweenKm andK (c)s for τa = 99min and an assumed distribution volume V¯ r = 0.53ml/ml. In
comparison with Figure 6, the systematic diﬀerence relative to the true Km is mostly removed even when Vr deviates distinctly from the assumed
value. Moving along the line, Vr ≈ 0.55 ml/ml between Km = 1 and 4 ml/min/100ml corresponds approximately to the experimental data of
Figure 2B.
quantitative whole-body investigations based on a DTP
acquisition. The only additional prerequisite is identiﬁca-
tion of the aorta or left ventricle in the DTP data. One
gains the ability to directly identify regions of elevated
irreversible FDG metabolism and to put the established
DTP approach on a quantitative basis. A further advan-
tage is the implied correction for the sizable inter-subject
variation of the blood tracer concentration (SUV range,
2.4 − 4.5 in this study). The latter correction alone clearly
improves the correlation between the derived parame-
ter (Ks) and the targeted one (Km). Another important
aspect is elimination of the dependence of SUV uptake
and retention index on the time of measurement(s). To
the extent that the Patlak model can be considered valid
(negligible k4), the proposed procedure yields a time-
independent result, namely a direct estimate of the invari-
ant rate Km which prospectively should allow deﬁnition
of improved, objective reference values. A further impli-
cation is elimination of any intra-scan time dependence
in whole-body/multi-bed studies. Last but not least, the
issue of ensuring correct SUV calibration is eliminated
since all calibration factors cancel out when perform-
ing an image-based determination of both TRF slope
and c0a. This observation seems especially relevant for
multi-center studies.
Conclusion
We have demonstrated that it is possible to derive a
quantitative estimate of Km, the metabolic trapping rate
of FDG, solely from a dual time point measurement.
We believe this approach to be of potential relevance
especially in the context of oncological whole-body inves-
tigations where the required AIF information is available
in the ﬁeld of view (aorta or left ventricle). In this case, the
approach eliminates most if not all issues of static SUV
and conventional dual time point imaging regarding the
inﬂuence of the chosen scan times relative to the time of
injection and the substantial inﬂuence of inter-study vari-
ability of the AIF. Consequently, the derived parameters
Ks and K (c)s exhibit a much improved stability and much
better correlation with the true Km. These properties
might prove especially relevant in the context of radia-
tion treatment planning and therapy response control.
Whether this is indeed the case has to be investigated in
appropriate future studies.
Appendix
We start with the standard Patlak formula but avoid divi-
sion by ca(t):a
ct(t) = Km ·
∫ t
0
ca(s)ds + Vr · ca(t), (5)
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where Km is the metabolic trapping rate, deﬁned by
Km = K1k3k2 + k3
and Vr is the apparent volume of distribution deﬁned by
Vr = K1k2








Equation 5 is valid for times t > T∗ where T∗ ≈ 20 to 30
min p.i.. Utilization of this equation for Km determination
requires measurements of the TRF only for t > T∗ but
measurement of the complete AIF starting at time zero.
We now want to eliminate the dependency on measure-
ments prior to T∗. By taking the time derivative at some
time point t > T∗, it follows directly from Equation 5 that
c˙t(t) = Km · ca(t) + Vr · c˙a(t)
or after division by ca(t) (suppressing the t argument)
c˙t
ca
= Km + Vr · c˙aca . (7)
Focusing on some speciﬁc time point t = t0, we use the
Taylor expansion of ca(t) around t0 (c(n)a (t0): nth derivative





n! (t − t0)
n. (8)
Introducing the parameters τn deﬁned by (−τn)n =
c0a/c
(n)
a (t0), Equation 8 can be rewritten as










1 − t − t0
τ1
+ 12!
( t − t0
τ2
)2




where τ0 is always equal to one. The parameters τn>0 are
constructed in such a way that for a mono-exponential
decrease of ca(t) near t0, we obtain τn>0 = τa, where τa is
the time constant of the exponential. Actually, it is known
that starting rather early after bolus injection (t > 20
min), ca(t) can be reasonably well described by a slow
mono-exponential decrease with a time constant τa ≈ 100
min (in the present study, we found an average value of
τa = 99 min, while a value of τa = 80 min was reported
in [18]).
Inserting the Taylor expansion from Equation 9 into
Equation 7, we get (c˙0t = c˙t(t0))
c˙0t
c0a
= Km − Vr
τ1
. (10)
In order to derive Km from this equation, we need to
reliably estimate c˙0t /c0a as well as to have knowledge of
1/τ1 (the fractional rate of decrease of the AIF at t =
t0). Obviously, direct determination of the time deriva-
tive c˙0t at t = t0 is not feasible in real (noisy) data. On
the other hand, it is not clear whether the average slope
over a necessarily rather large neighborhood (required for
reasons of limited time resolution and count rate statis-
tics) is an acceptable approximation of c˙0t (since the slope
changes over time). For investigation of this question,




) − ct (t0 − t2 ) for two time points lying sym-
metrically around t0 at a ﬁnite (possibly large) distance t













Replacing all occurrences of ca(t) in Equation 11
by the Taylor series in Equation 9 (neglecting fourth
and higher order terms) and executing the integra-
tion separately for each term of the series yield























The detailed derivation of Equation 12 is presented in
an additional ﬁle (see Additional ﬁle 1). The factors in
square brackets deviate only minimally from one up to
even quite large values oft. For the sake of simplicity, we
will demonstrate this only for the well-established approx-
imately mono-exponential behavior of ca(t) at later times
but emphasize that the conclusions remain the same when
using other reasonable parametrizations of the observed
shape of the AIF at later times (e.g., by an inverse power
law).
As already pointed out, for a mono-exponential
decrease of ca(t), all τn>0 coincide with the time constant
τa of the exponential. Consider, then, choosing t = 60
min in Equation 12 . Since τa ≈ 100 min, we have for both
square brackets 1 + 1/24 · 0.62 = 1.015. It is, therefore,








Thus, ct is to a very good approximation proportional
tot.t can become quite large, e.g.,t = 1 h, as long as
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the lower bound t0 − t2 remains larger than T∗. Deﬁning
the secant slopemt between c−t and c+t
mt = ct
t
and introducing the rate constant Ks
Ks = mtc0a
for the ratio of the secant slope and the blood concentra-
tion at t0, we get
Ks = mtc0a




Km = Ks + Vr
τa
. (14)
Comparison of Equation 13 with Equation 10 yields the
important result
mt = c˙0t .
In other words, the secant slope is to a very good approx-
imation equal to the instantaneous slope at t0 and thus
can be used instead. This in turn implies that the aver-
age slope of the TRF (derivable, e.g., by a least squares ﬁt
of a straight line in the considered time window), too, is
very nearly identical tomt . Note that these conclusions are
valid even if c˙t(t) varies considerably over the considered
time interval (see Figure 1). Formally, this result is iden-
tical to stating that a second-order Taylor expansion of
ct(t) around t0 turns out to be suﬃciently accurate within
t0 ± t/2.
The quantitative relation between Ks and Km is inves-
tigated in Figure 6. For this ﬁgure, we computed Km and
Vr over a range of sensible choices for the transport con-
stants K1, k2, and k3. The resulting Km and Vr (top row of
Figure 6) are used to compute Ks from Equation 13 for a
realistic value of τa (we chose τa = 99 min). The bottom
row in Figure 6 compares the true Km to Ks.
As can be seen (bottom right), the fractional devia-
tion of Ks from Km becomes large only when k3 is very
small (i.e., when there is virtually no trapping). Overall
Ks is a negatively biased estimator of Km, but an approx-
imate correction of the bias is possible considering the
following.
According to Equation 14, theVr and Km − Ks maps
in Figure 6 diﬀer only by a constant factor τa (and a
conversion factor of 100 due to the chosen units of
ml/min/100ml for Km and Ks). Moreover, Vr does vary
only modestly in comparison to the individual rate con-
stants and toKm (except when k3 becomes distinctly larger
than k2, but this is not observed in real data). Therefore,
Km − Ks does not vary much across the relevant part of
the k2/k3 plane.We, therefore, hypothesize that the diﬀer-
ence Km − Ks can be actually treated to be approximately
constant. Consequently, we propose to estimate Km using
only late time measurements of ca(t) and ct(t) as follows:
1. Determine the secant TRF slopemt in the time
interval t± = t0 ± t2 from a dual time point
measurement of ct(t) starting at suﬃciently late
times after injection, typically t > (20 − 30)min.
2. Estimate c0a = ca(t0) and τa from the exponential
connecting the two time points t−, t+.
3. Compute Ks = mt/c0a.
4. Compute a correction term K0 = V¯r/τa using the
individually determined τa and a ﬁxed value V¯r for
the distribution volume. In the absence of any
speciﬁc information regarding Vr in the investigated
tumor entity, we propose to use the average Vr
determined in this study, i.e., V¯r = 0.53ml/ml.
5. Finally, compute the corrected Ks, i.e.,
K (c)s = Ks + K0 = Ks + V¯r/τa (15)
as a quantitative estimate of the true Km.
According to Equations 14 and 15, K (c)s is equal to Km if
Vr = V¯r (irrespective of the values of K1- k3 yielding this
Vr value). Therefore, K (c)s remains a very good approxima-
tion of Km as long as Vr does not deviate too much from
the assumed value. This behavior is illustrated in Figure 7.
Endnote
aFor completeness, we mention that in the presence of
sizable fractional blood volume (fbv), the substitutions
Km → K∗m = (1 − fbv)Km and Vr → V ∗r = (1 − fbv)Vr +
fbv = Vr + fbv(1 − Vr) would have to be performed in
Equation 5 where the ‘asterisked’ quantities would be the
experimentally accessible ones.
Additional ﬁle
Additional ﬁle 1: Derivation of Equation 12. A pdf ﬁle showing the
complete derivation of Equation 12 using Taylor expansion.
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